Version 2024

2024 ICD-10-CM Diagnosis Code C90

Multiple myeloma and malignant plasma cell neoplasms

ICD-10-CM Code:
C90
ICD-10 Code for:
Multiple myeloma and malignant plasma cell neoplasms
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Malignant neoplasms of lymphoid, hematopoietic and related tissue
      (C81-C96)
      • Multiple myeloma and malignant plasma cell neoplasms
        (C90)

C90 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of multiple myeloma and malignant plasma cell neoplasms. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Multiple myeloma and malignant plasma cell neoplasms

Non-specific codes like C90 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for multiple myeloma and malignant plasma cell neoplasms:

  • C90.0 for Multiple myeloma - NON-BILLABLE CODE

  • Use C90.00 for Multiple myeloma not having achieved remission - BILLABLE CODE

  • Use C90.01 for Multiple myeloma in remission - BILLABLE CODE

  • Use C90.02 for Multiple myeloma in relapse - BILLABLE CODE

  • C90.1 for Plasma cell leukemia - NON-BILLABLE CODE

  • Use C90.10 for Plasma cell leukemia not having achieved remission - BILLABLE CODE

  • Use C90.11 for Plasma cell leukemia in remission - BILLABLE CODE

  • Use C90.12 for Plasma cell leukemia in relapse - BILLABLE CODE

  • C90.2 for Extramedullary plasmacytoma - NON-BILLABLE CODE

  • Use C90.20 for Extramedullary plasmacytoma not having achieved remission - BILLABLE CODE

  • Use C90.21 for Extramedullary plasmacytoma in remission - BILLABLE CODE

  • Use C90.22 for Extramedullary plasmacytoma in relapse - BILLABLE CODE

  • C90.3 for Solitary plasmacytoma - NON-BILLABLE CODE

  • Use C90.30 for Solitary plasmacytoma not having achieved remission - BILLABLE CODE

  • Use C90.31 for Solitary plasmacytoma in remission - BILLABLE CODE

  • Use C90.32 for Solitary plasmacytoma in relapse - BILLABLE CODE

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues Z85.79

Patient Education


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)

Learn about plasma cell neoplasm (including multiple myeloma) risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.